These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9124539)

  • 21. Mechanism of the stimulation of branched chain oxoacid oxidation in liver by carnitine.
    May ME; Aftring RP; Buse MG
    J Biol Chem; 1980 Sep; 255(18):8394-7. PubMed ID: 7410370
    [TBL] [Abstract][Full Text] [Related]  

  • 22. On the capacity of the beta-oxidation of palmitate and palmitoyl-esters in rat liver mitochondria.
    Farstad M; Berge R
    Acta Physiol Scand; 1978 Nov; 104(3):337-48. PubMed ID: 31061
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inactivation of medium-chain acyl-CoA dehydrogenase by oct-4-en-2-ynoyl-CoA.
    Zeng J; Deng G; Yu W; Li D
    Bioorg Med Chem Lett; 2006 Mar; 16(5):1445-8. PubMed ID: 16297616
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of carnitine on mitochondrial oxidation of palmitoylearnitine.
    Brass EP; Hoppel CL
    Biochem J; 1980 May; 188(2):451-8. PubMed ID: 7396873
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acyl-CoA dehydrogenase activity in the riboflavin-deficient rat. Effects of starvation.
    Ross NS; Hoppel CL
    Biochem J; 1987 Jun; 244(2):387-91. PubMed ID: 3663132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel mechanism for inhibition of beta-oxidation by methylenecyclopropylacetyl-CoA, a metabolite of hypoglycin.
    Osmundsen H; Sherratt HS
    FEBS Lett; 1975 Jul; 55(1):38-41. PubMed ID: 1140426
    [No Abstract]   [Full Text] [Related]  

  • 27. Medium-chain acyl-CoA dehydrogenase deficiency in children with non-ketotic hypoglycemia and low carnitine levels.
    Stanley CA; Hale DE; Coates PM; Hall CL; Corkey BE; Yang W; Kelley RI; Gonzales EL; Williamson JR; Baker L
    Pediatr Res; 1983 Nov; 17(11):877-84. PubMed ID: 6646897
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduction of beta-oxidation capacity of rat liver mitochondria by feeding orotic acid.
    Miyazawa S; Furuta S; Hashimoto T
    Biochim Biophys Acta; 1982 Jun; 711(3):494-502. PubMed ID: 7104378
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acylation of carnitine and glycerophosphate in suspensions of rat liver mitochondria at varying levels of palmitate and coenzyme A.
    Borrebaek B
    Acta Physiol Scand; 1975 Dec; 95(4):448-56. PubMed ID: 1211200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between acid-soluble carnitine and coenzyme A pools in vivo.
    Brass EP; Hoppel CL
    Biochem J; 1980 Sep; 190(3):495-504. PubMed ID: 7470064
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dicarboxylic aciduria: deficient [1-14C]octanoate oxidation and medium-chain acyl-CoA dehydrogenase in fibroblasts.
    Rhead WJ; Amendt BA; Fritchman KS; Felts SJ
    Science; 1983 Jul; 221(4605):73-5. PubMed ID: 6857268
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanism of hypoglycaemic action of methylenecyclopropylglycine.
    Melde K; Buettner H; Boschert W; Wolf HP; Ghisla S
    Biochem J; 1989 May; 259(3):921-4. PubMed ID: 2730593
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo stable isotope studies in three patients affected with mitochondrial fatty acid oxidation disorders: limited diagnostic use of 1-13C fatty acid breath test using bolus technique.
    Jakobs C; Kneer J; Martin D; Boulloche J; Brivet M; Poll-The BT; Saudubray JM
    Eur J Pediatr; 1997 Aug; 156 Suppl 1():S78-82. PubMed ID: 9266222
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypoglycin A: a specific inhibitor of isovaleryl CoA dehydrogenase.
    Tanaka K; Miller EM; Isselbacher KJ
    Proc Natl Acad Sci U S A; 1971 Jan; 68(1):20-4. PubMed ID: 5276292
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic deficiency of short-chain acyl-coenzyme A dehydrogenase in cultured fibroblasts from a patient with muscle carnitine deficiency and severe skeletal muscle weakness.
    Coates PM; Hale DE; Finocchiaro G; Tanaka K; Winter SC
    J Clin Invest; 1988 Jan; 81(1):171-5. PubMed ID: 3335634
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reye syndrome model in rats: protection against liver abnormalities by L-carnitine and acetyl-L-carnitine.
    Visentin M; Bellasio R; Tacconi MT
    J Pharmacol Exp Ther; 1995 Nov; 275(2):1069-75. PubMed ID: 7473134
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protection of rats by clofibrate against the hypoglycaemic and toxic effects of hypoglycin and pent-4-enoate. An ultrastructural and biochemical study.
    Van Hoof F; Hue L; Vamecq J; Sherratt HS
    Biochem J; 1985 Jul; 229(2):387-97. PubMed ID: 4038275
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of acetyl-carnitine oxidation in rat brown-adipose-tissue mitochondria by erucoyl-carnitine is due to sequestration of CoA.
    Alexson SE; Nedergaard J; Cannon B
    Biochim Biophys Acta; 1985 Apr; 834(2):149-58. PubMed ID: 3995059
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phytanic acid alpha-oxidation in rat liver mitochondria.
    Pahan K; Gulati S; Singh I
    Biochim Biophys Acta; 1994 Dec; 1201(3):491-7. PubMed ID: 7803482
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of fatty acid oxidation by acetyl-CoA generated from glucose utilization in isolated myocytes.
    Abdel-aleem S; Nada MA; Sayed-Ahmed M; Hendrickson SC; St Louis J; Walthall HP; Lowe JE
    J Mol Cell Cardiol; 1996 May; 28(5):825-33. PubMed ID: 8762022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.